Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00392236 · ClinicalTrials.gov registry record · NA
Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT00392236: Completed NA study, sponsored by Northwell Health.
NCT00392236 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00392236, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
This study will determine whether using a pager improves medication adherence in people with schizophrenia.
Primary Outcome
Estimated percent of prescribed medication taken during month 6 of the study was calculated using all available data sources (MEMS supplemented by subject interview and pill counts).
Interventions
- BEHAVIORAL Treatment as usual
- DEVICE 2-way pager
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-12 |
| Phase | NA |
What the finished NCT00392236 record still lists
NCT00392236 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Treatment as usual is the first listed.
NCT00392236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00392236 about?
NCT00392236 is a clinical study titled "Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers". This study will determine whether using a pager improves medication adherence in people with schizophrenia.
What is the current status of trial NCT00392236?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2006-04. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00392236?
The interventions under investigation include: Treatment as usual (BEHAVIORAL), 2-way pager (DEVICE).
Who is sponsoring clinical trial NCT00392236?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00392236's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia